m+Medelevator.RU
← Поиск публикаций
Frontiers in public health · 2026

Joinpoint regression and age-period-cohort analyses of global and Chinese acute hepatitis C incidence trends, 1990-2021.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Wu Menghan, Hong Cheng, Fang Yanjiao, Tao Jin, Zhang Xieyu, Cheng Guoming, Zhang Min, Tao Xianqing, Li Yuying, Ding Mengya, Dou Zhengdong

Аннотация

OBJECTIVE: This study aimed to analyse the temporal trends of acute hepatitis C incidence and the independent effects of age, time period, and birth cohort (age-period-cohort effects) from 1990 to 2021 globally and in China.

METHODS: Data were obtained from the Global Burden of Disease Study 2021. Joinpoint regression was used to analyse the trends in age-standardized incidence rates (ASIRs). The age-period-cohort model was employed to disentangle the underlying effects of population ageing, temporal changes, and birth cohort risks.

RESULTS: From 1990 to 2021, the global ASIR of acute hepatitis C exhibited an overall declining trend (average annual percent change [AAPC] = -0.38%). However, this trend reversed after 2015, indicating a concerning resurgence. Disparities were pronounced across socio-demographic index (SDI) levels: Low-SDI regions faced the highest burden, while the ASIR in China declined most rapidly (AAPC = -1.55%). The age-period-cohort analysis revealed a bimodal age pattern, with peaks in early childhood (0-4 years) and old age (≥95 years), indicating distinct transmission routes and historical cohort risks.

CONCLUSION: Despite a long-term decline, the global increase in acute hepatitis C incidence underscores an ongoing public health challenge. Our findings highlight the urgent need to strengthen prevention and screening strategies, particularly in low-SDI regions, among vulnerable age groups, and for high-risk populations in order to achieve the goal of hepatitis C elimination.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты